Lobbying registration dated 2026-02-05
Registrant: John Lewis
Client: Entos Pharmaceuticals
Targeted institutions:
Finance Canada (FIN)
Public Services and Procurement Canada (PSPC)
Innovation, Science and Economic Development Canada (ISED)
Prime Minister's Office (PMO)
Prairies Economic Development Canada (PrairiesCan)
Health Canada (HC)
Government funding received:
Institution: National Research Council (NRC)
Amount: 75000.00
Lobbying activity details:
Investment from governments are being requested to further Entos Pharmaceuticals' research and development of genetic medicines, as well as to assist in funding an innovation centre and manufacturing facility for genetic medicines.